Impact of disease exposure time and treatment in patients with migraine
DOI:
https://doi.org/10.25118/2763-9037.2023.v13.472Keywords:
migraine without aura, psychological distress, age of onset, time-to-treatment, migraine disorders, headacheAbstract
Introduction: migraine is responsible for the impact on functionality and psychological suffering of individuals who experience this condition. The severity of migraine symptoms and exposure time are associated with and relate to the age of onset of migraine and early treatment. Objective: The objective of this article is to verify whether there is an association between the time of exposure to migraine and the prevalence of depressive and anxious symptoms, as well as to identify the direct or indirect relationship between the duration of treatment on symptoms of psychiatric disorders and the decrease in the impact of migraine. disease in patients' lives. Method: this research constitutes a cross-sectional descriptive study, carried out at a unit specialized in migraine patient care with a sample divided into control group, episodic migraine, and chronic migraine. Results and conclusions: it was concluded that age-matched patients with either chronic migraine (CM) or episodic migraine (EM) reported similar headache onset periods, but have different treatment time (CM = 15 months and EM = 34 months). In addition, the chronic migraine group had higher disease burden.
Downloads
Metrics
References
Chen H, Chen G, Zheng X, Guo Y. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study. BMJ. 2019;364:l969. https://doi.org/10.1136/bmj.l969 PMID:30917970 - PMCID:PMC6435998
Souza NE, Calumby ML, Afonso EO, Nogueira TZS, Pereira ABCNG. Cefaleia: migrânea e qualidade de vida. Rev Saude. 2015;6(2):23-6. http://editora.universidadedevassouras.edu.br/index.php/RS/article/view/55
Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Goadsby PJ, Charles A. Migraine headache is present in the aura phase: a prospective study. Neurology. 2012;79(20):2044-9. https://doi.org/10.1212/WNL.0b013e3182749eed - PMID:23115208 - PMCID:PMC3511920
Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache. 2018;58 Suppl 1:4-16. https://doi.org/10.1111/head.13300 PMID:29697154
Organização Mundial da Saúde. Levantamento da incidência de cefaléia no Brasil. 2011. Disponível em: http://www.who.int/healthinfo/statistics/bod_migraine.pdf Acesso em: 5 set. 2015.
Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. https://doi.org/10.1177/0333102417738202 - PMID:29368949
May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455-64. https://doi.org/10.1038/nrneurol.2016.93 - PMID:27389092
Meletiche DM, Lofland JH, Young WB. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41(6):573-8. https://doi.org/10.1046/j.1526-4610.2001.041006573.x - PMID:11437893
Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301-15. https://doi.org/10.1177/0333102410381145 - PMID:20813784
Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428-32. https://doi.org/10.1136/jnnp.2009.192492 - PMID:20164501
Chen YC, Tang CH, Ng K, Wang SJ. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain. 2012;13(4):311-9. https://doi.org/10.1007/s10194-012-0447-4 PMID:22527034 - PMCID:PMC3356468
Raggi A, Giovannetti AM, Quintas R, D'Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain. 2012;13(8):595-606. https://doi.org/10.1007/s10194-012-0482-1 - PMID:23001069 - PMCID:PMC3484254
Schwedt TJ, Garza I. Acute treatment of migraine in adults. Waltham: UpToDate; 2022. https://www.uptodate.com/contents/acute-treatment-of-migraine-in-adults
Puledda F, Shields K. Non-pharmacological approaches for migraine. Neurotherapeutics. 2018;15(2):336-45. https://doi.org/10.1007/s13311-018-0623-6 - PMID:29616493 - PMCID:PMC5935652
Schwedt TJ. Preventive therapy of migraine. Continuum (Minneap Minn). 2018;24(4):1052-65. https://doi.org/10.1212/CON.0000000000000635 - PMID:30074549
Jesus CAS, Peres MFP. Review of major risk factors for chronic migraine. Headache Med. 2012;3(4):181-7. https://doi.org/10.48208/HeadacheMed.2012.28
Wells RE, O'Connell N, Pierce CR, Estave P, Penzien DB, Loder E, Zeidan F, Houle TT. Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med. 2021;181(3):317-28. https://doi.org/10.1001/jamainternmed.2020.7090 PMID:33315046 - PMCID:PMC7737157
Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7. https://doi.org/10.1001/archinte.166.10.1092 - PMID:16717171
Santos IS, Tavares BF, Munhoz TN, Almeida LSP, Silva NTB, Tams BD, Patella AM, Matijasevich A. Sensibilidade e especificidade do Patient Health Questionnaire-9 (PHQ-9) entre adultos da população geral. Cad Saude Publica. 2013;29(8):1533-43. https://doi.org/10.1590/S0102-311X2013001200006 PMID:24005919
Arenaza-Urquijo EM, Gonneaud J, Fouquet M, Perrotin A, Mézenge F, Landeau B, Egret S, De la Sayette V, Desgranges B, Chételat G. Interaction between years of education and APOE ε4 status on frontal and temporal metabolism. Neurology. 2015;85(16):1392-9. https://doi.org/10.1212/WNL.0000000000002034 - PMID:26408498 - PMCID:PMC4626241
Van Gerven PWM, Meijer WA, Jolles J. Education does not protect against age-related decline of switching focal attention in working memory. Brain Cogn. 2007;64(2):158-63. https://doi.org/10.1016/j.bandc.2007.02.005 - PMID:17397977
Bao J, Ma M, Dong S, Gao L, Li C, Cui C, Chen N, Zhang Y, He L. Early age of migraine onset is independently related to cognitive decline and symptoms of depression affect quality of life. Curr Neurovasc Res. 2020;17(2):177-87. https://doi.org/10.2174/1567202617666200207130659 PMID:32031072 - PMCID:PMC7536790
Charles JA, Peterlin BL, Rapoport AM, Linder SL, Kabbouche MA, Sheftell FD. Favorable outcome of early treatment of new onset child and adolescent migraine: implications for disease modification. J Headache Pain. 2009;10(4):227-33. https://doi.org/10.1007/s10194-009-0133-3 - PMID:19506799 PMCID:PMC3451739
Hu XH, Ng-Mak D, Cady R. Does early migraine treatment shorten time to headache peak and reduce its severity? Headache. 2008;48(6):914-20. https://doi.org/10.1111/j.1526-4610.2007.00955.x PMID:18005142
Landy SH, Runken MC, Bell CF, Higbie RL, Haskins LS. Examining the interrelationship of migraine onset, duration, and time to treatment. Headache. 2012;52(3):363-73. https://doi.org/10.1111/j.1526-4610.2011.02029.x - PMID:22077159
Gendolla A. Early treatment in migraine: how strong is the current evidence? Cephalalgia. 2008;28 Suppl 2:28-35. https://doi.org/10.1111/j.1468-2982.2008.01688.x - PMID:18715330
Klan T, Liesering-Latta E, Gaul C, Martin PR, Witthoft M. An integrative cognitive behavioral therapy program for adults with migraine: a feasibility study. Headache. 2019;59(5):741-55. https://doi.org/10.1111/head.13532 - PMID:30970172
Galvez-Sánchez CM, Montoro CI, Moreno-Padilla M, Del Paso GAR, de la Coba P. Effectiveness of acceptance and commitment therapy in central pain sensitization syndromes: a systematic review. J Clin Med. 2021;10(12):2706. https://doi.org/10.3390/jcm10122706 - PMID:34205244 PMCID:PMC8235706
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Thaís Brito Vilela, Pedro Henrique Ribeiro da Cunha, Rodrigo Nicolato, Isabela Maria Magalhães Lima
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
